First-in-Human trial of DS9051b in participants with advanced solid tumors
DS9051-079
Phase 1 other active
Quick answer
First-in-Human trial of DS9051b in participants with advanced solid tumors for Advanced or Metastatic Adrenocortical Carcinoma (ACC), Metastatic Castration-resistant Prostate Cancer (CRPC) is a Phase 1 program (other) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo Europe GmbH
- Indication
- Advanced or Metastatic Adrenocortical Carcinoma (ACC), Metastatic Castration-resistant Prostate Cancer (CRPC)
- Phase
- Phase 1
- Modality
- other
- Status
- active